PULMONARY LYMPHANGIOMATOSIS REVEALED BY AN INTERSTITIAL SYNDROME IN A YOUNG ADULT

##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Vol. 87 No. 4 (2009): Issue Apr 2009

##plugins.themes.academic_pro.article.main##

Lilia Kria Ben Mahmoud
Amira Arfaoui Toumi
Ines Chaâr
Ahlem Lahmer
Tahar khalfallah
Sabeh Regaya Mzabi
Saadia Bouraoui

Abstract

Background: The p73 gene encodes a nuclear protein that is highy homologous to p53. p73 also shares some common functions with p53 protein indicating that p73 gene is a p53-like tumor suppressor.
Aim: In this study, we examined by immunohistochemestry the p73 expression on 120 cases of colorectal carcinomas and evaluated its implication in carcinogenesis.
Methods: Retrospective study.
Results: The results show an increase of intensity and distribution of p73 in common adenocarcinoma from the normal mucosa, to primery tumors and to metastases. However, in mucinous adenocarcinomas, immunostaining of p73 decrease in primary tumor and completely diseappears in isolated cells and metastases compared with matched normal mucosa. These observations are further reinforced by the fact that in adenocarcinoma with mucinous component less than 50%, the positivity of p73 persist in well-differentiated areas and dramatically decreases or completely deseappears in mucinous areas.
Conclusion: In conclusion, p73 would be a prognosic marker for the common adenocarcinomas and an ethiopathogenic factor for the mucinous subtype.

Keywords:

Colorectal carcinomas, p73, immunohistochemestry

##plugins.themes.academic_pro.article.details##

References

  1. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancer. Cell 1997;90: 809-19.
  2. Jost CA, Martin MC, Kaelin WG, Jr. p73 is a human p53-related protein that can induce apoptosis. Nature (Lond.) 1997;389: 191-4.
  3. Sun XF. p73 Overexpression Is a Prognostic Factor in Patients with Colorectal Adenocarcinoma. Clinical Cancer Research 2002; 8:165-70.
  4. Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T et al. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 1999;18: 1061-6.
  5. Sunahara M, Ichimiya S, Nimura Y, Takada N, Sakiyama S, Sato Y, et al. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int J Oncol 1998;13: 319-23.
  6. Takahashi H, Ichimiya S, Nimura Y, Watanabe M, Furusato M, Wakui S, et al. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res 1998;58: 2076-7.
  7. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi T, et al. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 1998;58: 1380-3.
  8. Sun XF. p73 overexpression is a prognostic factor in patient with colorectal adenocarcinoma. Clin Cancer Res 2002;8:165-70.
  9. Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, et al. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 1999;91:1154-8.
  10. Zaika AI, Kovalev S, Marchenko ND, Moll UM. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res 1999;59:3257-63.
  11. Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI, et al. Activation of p73 silent allele in lung cancer. Cancer Res 1998; 58: 2347-9.
  12. Tokuchi Y, Hashimoto T, Kobayashi Y, Hayashi M, Nishida K, Hayashi S, et al. The expression of p73 is increased in lung cancer, independent of p53 gene alteration. Br J Cancer 1999;80:1623-9.
  13. Chi SG, Chang SG, Lee SJ, Lee CH, Kim JI, Park JH. Elevated and biallelic expression of p73 is associated with progression of human bladder cancer. Cancer Res 1999;59:2791-3
  14. Nimura Y, Mihara M, Ichimiya S, Sakiyama S, Seki N, Ohira M, et al. p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer 1998;78:437-40.
  15. Kang MJ, Park BJ, Byun DS, Park JI, Kim HJ, Park JH, et al. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin Cancer Res 2000;6:1767-71.
  16. Sunahara M, Ichimiya S, Nimura Y, Takada N, Sakiyama S, Sato Y, et al. Mutational analysis of the p73 gene localizated at chromosome 1p36.3 in colorectal carcinomas. Int J Oncol 1998; 13:319-23.
  17. Ng SW, Yiu GK, Liu Y, Huang LW, Palnati M, Jun SH, et al. Analysis of p73 in human borderline and invasive ovarian tumor. Oncogene 2000;19:1885-90.
  18. Chen CL, Ip SM, Cheng D, Wong LC, Ngan HY. p73 gene expression in ovarian cancer tissues and cell lines. Clin Cancer Res 2000;6:3910-5.
  19. Zwahlen D, Tschan MP, Grob TJ, Peters UR, Fink D, Haenggi W, et al. Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours. Int J Cancer 2000;88:66- 70.
  20. Herath NI, Kew MC, Whitehall VL, Walsh MD, Jass JR, Khanna KK, et al. p73 is up-regulated in a subset of hepatocellular carcinomas. Hepatology 2000;31:601-5.
  21. Kroiss MM, Bosserhoff AK, Vogt T, Buettner R, Bogenrieder T, Landthaler M, et al. Loss of expression or mutation in the p73 tumor suppressor gene are not involved in the pathogenesis of malignant melanomas. Melanoma Res 1998;8: 504-9.
  22. Kovalev S, Marchenko N, Swendeman S, LaQuaglia M, Moll UM. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ 1998;9: 897-903.
  23. Pfeifer D, Ardman G, Sun X-F. Polymorphism of the p73 gene in relation to colorectal cancer risk and survival. Carcinogenesis 2005 26:103-107.